FR2403343A1 - Ethers de l'acide clavulanique, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Ethers de l'acide clavulanique, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
FR2403343A1
FR2403343A1 FR7826106A FR7826106A FR2403343A1 FR 2403343 A1 FR2403343 A1 FR 2403343A1 FR 7826106 A FR7826106 A FR 7826106A FR 7826106 A FR7826106 A FR 7826106A FR 2403343 A1 FR2403343 A1 FR 2403343A1
Authority
FR
France
Prior art keywords
ethers
preparation
clavulanic acid
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7826106A
Other languages
English (en)
French (fr)
Other versions
FR2403343B1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of FR2403343A1 publication Critical patent/FR2403343A1/fr
Application granted granted Critical
Publication of FR2403343B1 publication Critical patent/FR2403343B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/16Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
    • C07D203/20Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carbonic acid, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
FR7826106A 1977-09-16 1978-09-12 Ethers de l'acide clavulanique, procede pour leur preparation et compositions pharmaceutiques les contenant Granted FR2403343A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3864977 1977-09-16
GB2404778 1978-05-30

Publications (2)

Publication Number Publication Date
FR2403343A1 true FR2403343A1 (fr) 1979-04-13
FR2403343B1 FR2403343B1 (es) 1980-06-13

Family

ID=26256866

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7826106A Granted FR2403343A1 (fr) 1977-09-16 1978-09-12 Ethers de l'acide clavulanique, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (19)

Country Link
JP (1) JPS5452093A (es)
AR (1) AR218504A1 (es)
AT (1) ATA664078A (es)
AU (1) AU3974778A (es)
CA (1) CA1121821A (es)
CH (1) CH640536A5 (es)
DE (1) DE2839426A1 (es)
DK (1) DK410378A (es)
ES (1) ES473414A1 (es)
FI (1) FI782791A (es)
FR (1) FR2403343A1 (es)
GB (1) GB2004541B (es)
GR (1) GR65657B (es)
IT (1) IT7851089A0 (es)
LU (1) LU80244A1 (es)
NL (1) NL7809400A (es)
NO (1) NO783132L (es)
PT (1) PT68513A (es)
SE (1) SE7809747L (es)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2339616A1 (fr) * 1976-01-31 1977-08-26 Beecham Group Ltd Composes therapeutiques contenant un cycle b-lactame
FR2369281A1 (fr) * 1976-10-30 1978-05-26 Beecham Group Ltd Composes a cycle b-lactame utilisables comme medicaments
FR2372837A1 (fr) * 1976-12-03 1978-06-30 Beecham Group Ltd Nouveaux ethers de l'acide clavulanique, utilisables comme medicaments

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2339616A1 (fr) * 1976-01-31 1977-08-26 Beecham Group Ltd Composes therapeutiques contenant un cycle b-lactame
FR2369281A1 (fr) * 1976-10-30 1978-05-26 Beecham Group Ltd Composes a cycle b-lactame utilisables comme medicaments
FR2372837A1 (fr) * 1976-12-03 1978-06-30 Beecham Group Ltd Nouveaux ethers de l'acide clavulanique, utilisables comme medicaments

Also Published As

Publication number Publication date
DE2839426A1 (de) 1979-03-29
JPS5452093A (en) 1979-04-24
IT7851089A0 (it) 1978-09-14
FR2403343B1 (es) 1980-06-13
NL7809400A (nl) 1979-03-20
SE7809747L (sv) 1979-03-17
CA1121821A (en) 1982-04-13
AR218504A1 (es) 1980-06-13
ES473414A1 (es) 1979-11-01
ATA664078A (de) 1982-06-15
GB2004541A (en) 1979-04-04
FI782791A (fi) 1979-03-17
NO783132L (no) 1979-03-19
CH640536A5 (de) 1984-01-13
AU3974778A (en) 1980-03-20
GR65657B (en) 1980-10-16
LU80244A1 (fr) 1979-03-07
PT68513A (en) 1978-10-01
GB2004541B (en) 1982-05-12
DK410378A (da) 1979-03-17

Similar Documents

Publication Publication Date Title
FR2405946A1 (fr) Nouveaux derives de l'acide 3-methyl-crotonique et procede pour leur preparation
FR2384765A1 (fr) Derives amino-substitues du furanne et procede pour leur preparation
FR2430934A1 (fr) Nouveaux prostanoides et procede pour leur preparation
FR2430412A1 (fr) Derives substitues de propanolamine utiles comme medicaments et procede de leur preparation
FR2357541A1 (fr) Composes polyeniques et leur procede de preparation
FR2444031A1 (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
FR2430419A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2401914A1 (fr) Nouveaux composes heterocycliques, procede pour leur preparation et compositions medicinales contenant lesdits composes
FR2397403A1 (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2374307A1 (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
FR2433527A1 (fr) Nouveaux derives de type pyrimidinone, procede pour leur preparation et composition pharmaceutique les contenant
FR2416892A1 (fr) Derives de pyrido(1,2-a)pyrimidines, procede pour leur preparation et compositions pharmaceutiques qui les contiennent
FR2436149A1 (fr) Nouveaux aminoglucosides, leur preparation et leur application comme medicaments
FR2401144A1 (fr) Derives de benzimidazole contenant du soufre, procede pour leur preparation et intermediaires utiles pour leur production
FR2362845A1 (fr) Nouveaux derives de o-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2436144A1 (fr) Nouveaux derives d'aurones, leur procede de preparation et leur utilisation comme produits pharmaceutiques
FR2402644A1 (fr) Nouveaux nitroethylcyclopentanes utiles comme intermediaires pour la synthese des prostaglandines, et leur procede de preparation
FR2403343A1 (fr) Ethers de l'acide clavulanique, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2404001A1 (fr) Derives d'oxazolidone-2 utiles comme medicaments et procedes pour leur preparation
FR2379532A1 (fr) Nouveaux derives de l'acide oxamique, leur preparation et leur application comme medicaments
FR2397418A1 (fr) Esters de penicilline utilisables comme medicaments et procede pour leur preparation
FR2442236A1 (es)
FR2378015A1 (fr) Nouveaux derives de la benzo(f)isoquinoleine, leur preparation et leur application comme medicaments
FR2355839A1 (fr) Derives optiquement actifs d'acide benzoxazolyl-propionique, procede pour leur preparation et compositions therapeutiques les contenant
FR2372837A1 (fr) Nouveaux ethers de l'acide clavulanique, utilisables comme medicaments

Legal Events

Date Code Title Description
ST Notification of lapse